Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 1,000 shares of the business’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $25.00, for a total transaction of $25,000.00. Following the completion of the transaction, the chief executive officer owned 185,952 shares of the company’s stock, valued at approximately $4,648,800. This represents a 0.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $31.84, for a total transaction of $15,633.44.
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90.
Trupanion Price Performance
Shares of Trupanion stock opened at $26.32 on Wednesday. The firm has a market cap of $1.15 billion, a PE ratio of 49.66, a P/E/G ratio of 1.77 and a beta of 1.45. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The business has a 50-day moving average price of $27.38 and a 200 day moving average price of $25.77.
Institutional Investors Weigh In On Trupanion
Large investors have recently made changes to their positions in the stock. Kelleher Financial Advisors purchased a new stake in Trupanion in the 2nd quarter valued at $42,000. Parallel Advisors LLC raised its holdings in shares of Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares during the period. Quantbot Technologies LP purchased a new position in shares of Trupanion during the 2nd quarter worth $89,000. Fifth Third Bancorp boosted its position in shares of Trupanion by 2,911.1% during the 1st quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after acquiring an additional 7,336 shares during the last quarter. Finally, Arizona State Retirement System boosted its position in shares of Trupanion by 7.7% during the 2nd quarter. Arizona State Retirement System now owns 9,587 shares of the financial services provider’s stock valued at $237,000 after acquiring an additional 688 shares during the last quarter.
Analyst Ratings Changes
Several analysts have recently issued reports on TRUP shares. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. Stifel Nicolaus boosted their price objective on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Atlantic Securities set a $42.00 target price on Trupanion in a report on Wednesday, July 15th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Finally, Weiss Ratings downgraded Trupanion from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, September 10th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $39.20.
About Trupanion
Trupanion, Inc is a pet insurance company that provides medical coverage for cats and dogs. Its subscription-based policies are designed to help pet owners manage the cost of eligible veterinary care, including coverage for unexpected illnesses and injuries. Depending on the policy and jurisdiction, coverage may include diagnostic tests, surgeries, hospital stays and prescription medications, subject to applicable terms, exclusions and deductibles.
The company also develops technology intended to simplify the relationship between pet owners, veterinarians and insurers.
Further Reading
- Five stocks we like better than Trupanion
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
